Christopher B. Sherrill
Luminex Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher B. Sherrill.
Clinical Chemistry | 2003
Michael J. Moser; David J. Marshall; Jennifer K. Grenier; Collin D. Kieffer; Anthony A. Killeen; Jerod L. Ptacin; Craig S. Richmond; Eric B. Roesch; Christopher W. Scherrer; Christopher B. Sherrill; Cris V. Van Hout; Sara J. Zanton; James R. Prudent
BACKGROUND With the invention of the DNA chip, genome-wide analysis is now a reality. Unfortunately, solid-phase detection systems such as the DNA chip suffer from a narrow range in quantification and sensitivity. Today the best methodology for sensitive, wide dynamic range quantification and genotyping of nucleic acids is real-time PCR. However, multiplexed real-time PCR technologies require complicated and costly design and manufacturing of separate detection probes for each new target. METHODS We developed a novel real-time PCR technology that uses universal energy transfer probes constructed from An Expanded Genetic Information System (AEGIS) for both quantification and genotyping analyses. RESULTS RNA quantification by reverse transcription-PCR was linear over four orders of magnitude for the simultaneous analysis of beta-actin messenger RNA and 18S ribosomal RNA. A single trial validation study of 176 previously genotyped clinical specimens was performed by endpoint analysis for factor V Leiden and prothrombin 20210A mutation detection. There was concordance for 173 samples between the genotyping results from Invader tests and the AEGIS universal energy transfer probe system for both factor V Leiden and prothrombin G20210A. Two prothrombin and one factor V sample gave indeterminate results (no calls). CONCLUSION The AEGIS universal probe system allows for rapid development of PCR assays for nucleic acid quantification and genotyping.
Nucleic Acids Research | 2004
Scott C. Johnson; Christopher B. Sherrill; David J. Marshall; Michael J. Moser; James R. Prudent
Clinical Chemistry | 2004
Scott C. Johnson; David J. Marshall; Gerda Harms; Christie M. Miller; Christopher B. Sherrill; Edward L. Beaty; Scott A. Lederer; Eric B. Roesch; Gary Madsen; Gary L. Hoffman; Ronald H. Laessig; Greg J. Kopish; Mei W. Baker; Steven A. Benner; Philip M. Farrell; James R. Prudent
Archive | 2001
David J. Marshall; James R. Prudent; Christopher B. Sherrill; Gideon Shapiro; Jennifer K. Grenier; Craig S. Richmond; Simona Jurczyk; Jerod L. Ptacin
Archive | 2001
Jennifer K. Grenier; David J. Marshall; James R. Prudent; Craig S. Richmond; Eric B. Roesch; Christopher W. Scherrer; Christopher B. Sherrill; Jerod L. Ptacin
Archive | 2006
Kelvin Ho; Hanying Li; Eric B. Roesch; Christopher B. Sherrill; James R. Prudent; Thomas H. LaBean
Archive | 2005
James R. Prudent; Christopher B. Sherrill
Archive | 2005
James R. Prudent; Christopher B. Sherrill
Journal of the American Chemical Society | 2005
Christopher B. Sherrill; David J. Marshall; Michael J. Moser; Christine A. Larsen; and Lygia Daudé-Snow; James R. Prudent
Archive | 2001
Jennifer K. Grenier; David J. Marshall; James R. Prudent; Craig S. Richmond; Eric B. Roesch; Christopher W. Scherrer; Christopher B. Sherrill; Jerod L. Ptacin